Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone: A Randomized Clinical Trial and Follow-up Study

IMPORTANCE: Extended-release naltrexone (XR-NTX) is a promising alternative treatment of opioid addiction but has never been compared with opioid agonist treatment for effects on symptoms of anxiety, depression, and insomnia. OBJECTIVE: To investigate whether XR-NTX unmasks or reinforces current com...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Psychiatry
Main Authors: Latif, Zill-e-Huma, Šaltytė Benth, Jūratė, Solli, Kristin Klemmetsby, Opheim, Arild, Kunoe, Nikolaj, Krajci, Peter, Sharma-Haase, Kamni, Tanum, Lars
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2018
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6439739/
https://ncbi.nlm.nih.gov/pubmed/30566177
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamapsychiatry.2018.3537
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados